Edwards Lifesciences Corp (EW) stock
EWNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 10/3058% above fair value
$105.80−0.01 (-0.01%)
Close on Nov 12, 2026Market cap $60.98BP/E 59.8Yield –
Edwards Lifesciences cash
Cash and short-term investments held at the end of each period.
Edwards Lifesciences's cash was $4.64B at Sep 30, 2026. For fiscal 2025 it was $4.23B, up 5.9% from the year before. Over ten years it grew 13.2% a year on average. The highest annual figure on record is $4.23B in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.23B | +5.9% |
| FY2024 | Dec 31, 2024 | $3.99B | +142.0% |
| FY2023 | Dec 31, 2023 | $1.65B | +35.2% |
| FY2022 | Dec 31, 2022 | $1.22B | -17.2% |
| FY2021 | Dec 31, 2021 | $1.47B | +3.6% |
| FY2020 | Dec 31, 2020 | $1.42B | -6.7% |
| FY2019 | Dec 31, 2019 | $1.52B | +58.8% |
| FY2018 | Dec 31, 2018 | $958.30M | -28.5% |
| FY2017 | Dec 31, 2017 | $1.34B | +5.4% |
| FY2016 | Dec 31, 2016 | $1.27B | +3.8% |
| FY2015 | Dec 31, 2015 | $1.22B | -14.9% |
| FY2014 | Dec 31, 2014 | $1.44B | +53.6% |
| FY2013 | Dec 31, 2013 | $936.90M | +201.4% |
| FY2012 | Dec 31, 2012 | $310.90M | +81.6% |
| FY2011 | Dec 31, 2011 | $171.20M | -56.8% |
| FY2010 | Dec 31, 2010 | $396.10M | +18.6% |
| FY2009 | Dec 31, 2009 | $334.10M | +52.8% |
| FY2008 | Dec 31, 2008 | $218.70M | +54.2% |
| FY2007 | Dec 31, 2007 | $141.80M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $4.64B | +20.6% |
| Q2 FY2026 | Jun 30, 2026 | $4.25B | +4.2% |
| Q1 FY2026 | Mar 31, 2026 | $3.67B | -6.0% |
| Q4 FY2025 | Dec 31, 2025 | $4.23B | +5.9% |
| Q3 FY2025 | Sep 30, 2025 | $3.85B | -13.5% |
| Q2 FY2025 | Jun 30, 2025 | $4.08B | +103.6% |
| Q1 FY2025 | Mar 31, 2025 | $3.91B | +129.5% |
| Q4 FY2024 | Dec 31, 2024 | $3.99B | +142.0% |
| Q3 FY2024 | Sep 30, 2024 | $4.45B | +138.4% |
| Q2 FY2024 | Jun 30, 2024 | $2.00B | +32.3% |
| Q1 FY2024 | Mar 31, 2024 | $1.70B | +35.3% |
| Q4 FY2023 | Dec 31, 2023 | $1.65B | +35.2% |
| Q3 FY2023 | Sep 30, 2023 | $1.87B | +7.2% |
| Q2 FY2023 | Jun 30, 2023 | $1.51B | -0.4% |
| Q1 FY2023 | Mar 31, 2023 | $1.26B | -16.1% |
| Q4 FY2022 | Dec 31, 2022 | $1.22B | -17.2% |
| Q3 FY2022 | Sep 30, 2022 | $1.74B | -3.6% |
| Q2 FY2022 | Jun 30, 2022 | $1.52B | -3.4% |
| Q1 FY2022 | Mar 31, 2022 | $1.50B | +11.4% |
| Q4 FY2021 | Dec 31, 2021 | $1.47B | +3.6% |
| Q3 FY2021 | Sep 30, 2021 | $1.81B | +39.0% |
| Q2 FY2021 | Jun 30, 2021 | $1.57B | +34.6% |
| Q1 FY2021 | Mar 31, 2021 | $1.35B | +30.0% |
| Q4 FY2020 | Dec 31, 2020 | $1.42B | -6.7% |
| Q3 FY2020 | Sep 30, 2020 | $1.30B | -4.1% |
| Q2 FY2020 | Jun 30, 2020 | $1.17B | +25.2% |
| Q1 FY2020 | Mar 31, 2020 | $1.04B | +7.6% |
| Q4 FY2019 | Dec 31, 2019 | $1.52B | +58.8% |
| Q3 FY2019 | Sep 30, 2019 | $1.36B | -15.0% |
| Q2 FY2019 | Jun 30, 2019 | $934.30M | -33.3% |
| Q1 FY2019 | Mar 31, 2019 | $963.00M | -35.8% |
| Q4 FY2018 | Dec 31, 2018 | $958.30M | -28.5% |
| Q3 FY2018 | Sep 30, 2018 | $1.60B | +13.8% |
| Q2 FY2018 | Jun 30, 2018 | $1.40B | +23.8% |
| Q1 FY2018 | Mar 31, 2018 | $1.50B | +63.3% |
| Q4 FY2017 | Dec 31, 2017 | $1.34B | +5.4% |
| Q3 FY2017 | Sep 30, 2017 | $1.40B | – |
| Q2 FY2017 | Jun 30, 2017 | $1.13B | – |
| Q1 FY2017 | Mar 31, 2017 | $918.20M | – |
| Q4 FY2016 | Dec 31, 2016 | $1.27B | – |
See a number that looks wrong?